https://www.nature.com/articles/s41467-026-77910-5
chatGPT(6AstraMaxPaid):
The paper provides credible evidence that excessive MCT4-mediated lactate export contributes to some defects in aged mouse oocytes. Its strongest features are paired RNA and protein measurements from individual oocytes, followed by functional experiments. The human findings remain observational, and the proposed clinical applications require substantial validation.
The paper is Cao et al., Single-oocyte proteome-transcriptome co-profiling reveals a role of dysregulated lactate metabolism in oocyte aging, published in Nature Communications in September 2026.
Summary: The authors investigate how ageing changes oocyte proteins, how those changes relate to RNA abundance, and whether an identified metabolic abnormality contributes to declining function.
They use scSTAP, which divides the contents of an individual oocyte between RNA sequencing and mass spectrometry.
| Study component | Samples and design |
|---|---|
| Mouse molecular profiling | 120 oocytes from young mice aged 6-8 weeks and older mice aged 12-14 months |
| Human molecular profiling | 85 oocytes from 59 women: younger donors aged 21-33 and older donors aged 35-46 |
| Developmental stages | Germinal vesicle, or GV, and metaphase II, or MII |
| Human sample preparation | GV oocytes collected during assisted reproduction; MII oocytes produced by maturation in culture |
| Coverage across the datasets | Approximately 4,000 mouse proteins and 6,800 human proteins, with considerably broader RNA coverage |
Those protein counts describe coverage across datasets, rather than guaranteed detection in every individual oocyte.
The principal findings are:
-
RNA abundance is a weak predictor of protein abundance. RNA-protein correlations were generally below 0.3, and ageing frequently changed proteins without corresponding RNA changes. Experiments inhibiting translation or proteasomal degradation supported contributions from both processes. Analysis of published human translation data provided additional supporting evidence.
-
Ageing affects oocytes unevenly. The authors identified groups of older oocytes with differing molecular abnormalities, including variation among oocytes from the same donor. Changes also depended strongly on developmental stage and species. Many individual changes in mice were absent in humans.
-
MCT4 emerged as a shared candidate contributor. This transporter exports lactate together with protons. Its abundance increased in aged GV oocytes in both species, particularly among oocytes showing more pronounced molecular abnormalities.
-
Mouse experiments support a functional role for MCT4. Increasing MCT4 in young oocytes produced several defects associated with ageing. Reducing MCT4 using siRNA, or inhibiting it with VB124, improved maturation, spindle organisation, chromosome alignment and fertilisation in aged oocytes.
-
The proposed mechanism involves loss of mitochondrial fuel availability. Aged mouse oocytes exported more lactate and contained less cytosolic lactate, lower mitochondrial pyruvate sensor signals, fewer measured TCA-cycle intermediates and less ATP. MCT4 inhibition improved these measurements. Pyruvate supplementation also improved ATP levels and oocyte function, supporting the proposed mechanism.
-
Treatment produced some benefits in living mice. Fifteen days of VB124 treatment improved several oocyte measurements, reduced follicular apoptosis and partially increased litter size. The litter-size experiment involved six biological replicates per group.
-
Human lactate measurements tracked reproductive-ageing indicators. Oocyte lactate release was assessed in 18 donors, and follicular-fluid lactate in a separate cohort of 83 donors. Higher lactate was associated with greater age, lower anti-Mullerian hormone, or AMH, and fewer retrieved oocytes.
Novelty: The main advance is the combination of paired molecular measurements, human-mouse comparisons, individual-oocyte heterogeneity and functional investigation of MCT4.
The scSTAP technology itself was published in 2023. Single-oocyte proteomic analysis of ageing also predates this paper, including a 2025 study with extensive protein coverage. The present contribution is therefore chiefly the integrated application and the biological mechanism it identifies. (pubmed.ncbi.nlm.nih.gov)
The strongest biological novelty is the evidence connecting increased MCT4 activity to impaired aged-oocyte function, with improvement after intervention. The broader concept that lactate export can compete with mitochondrial pyruvate metabolism already had experimental support in cardiac research. This paper extends that mechanism into reproductive ageing. (sciencedirect.com)
Critique: The study is strengthened by testing its candidate mechanism in several ways: overexpression, knockdown, pharmacological inhibition, metabolic supplementation and treatment in living animals. These converging experiments make the MCT4 findings more persuasive than a correlation discovered through profiling alone.
However, several limitations affect interpretation.
-
The metabolic mechanism is supported, but not completely demonstrated.
The authors measure metabolite abundance and ATP content. These measurements do not directly establish the rate of pyruvate entry into mitochondria, carbon flow through the TCA cycle, or ATP synthesis.
Isotope tracing would help establish whether increased lactate export actually redirects pyruvate carbon away from mitochondrial oxidation. Because MCT4 transports protons, associated changes in pH and cellular redox balance could also contribute to the functional effects.
-
The mitochondrial pyruvate measurement has a specific technical vulnerability.
PyronicSF, the sensor used, is pH-sensitive. Its original validation describes controls to distinguish pyruvate responses from pH effects. (PMC)
This matters because the oocyte study itself reports MCT4-associated intracellular pH changes. The main methods describe normalisation to mCherry, but do not describe a matched mitochondrial pH correction or a pyruvate-insensitive sensor control. This leaves a potential confound in the mitochondrial measurement, although the separate metabolomics results provide supporting evidence for altered metabolism.
-
The human samples represent a selected population.
Human oocytes came from stimulated assisted-reproduction cycles. The investigators used immature GV oocytes available for research, and generated the MII samples through laboratory maturation.
Consequently, the results may reflect interactions between age, stimulation response and failure to mature before retrieval. Comparisons with mouse MII oocytes also mix species differences with different maturation conditions.
-
The proposed human biomarker has not been validated against individual-oocyte outcomes.
Age, AMH and oocyte yield are relevant reproductive measures, but they do not directly establish whether a particular oocyte can produce a healthy embryo or live birth.
The study does not establish whether lactate adds predictive information beyond donor age and ovarian reserve. Follicular-fluid lactate also has several possible cellular sources, including granulosa cells. The authors acknowledge this and the absence of a dedicated blood-contamination control.
-
The statistical analysis warrants caution.
Differential-expression discovery generally uses nominal P values below 0.05 alongside fold-change thresholds. Adjusted P values are supplied, but the stated discovery criteria do not consistently require significance after correction for thousands of comparisons. Some exploratory findings may therefore be false positives.
Multiple oocytes also came from some donors, while analyses generally treat oocytes as independent samples. Accounting for donor-level clustering would strengthen the results.
Investigators were not blinded. Randomisation reporting is inconsistent: the animal-treatment methods describe random allocation, whereas the general statistical section says experiments were not randomised.
-
The two ageing groups are exploratory molecular classifications.
Clustering identifies variation, but does not establish two discrete biological states. A continuous range of impairment could produce a similar result.
Moreover, the same dataset helps define the groups and identify their distinguishing markers. Independent validation against subsequent developmental outcomes would be more convincing. Enrichment for senescence-associated gene sets also does not establish that oocytes undergo conventional cellular senescence.
-
RNA-protein uncoupling needs interpretation in the context of stored maternal RNA.
Mature oocytes depend heavily on previously accumulated RNA and proteins. A snapshot of present RNA abundance therefore need not match proteins produced over an earlier period.
The authors explicitly recognise this. Their results support substantial post-transcriptional regulation, but cannot establish that earlier transcriptional changes are unimportant. The reported analyses also do not directly resolve altered splice isoforms or splicing fidelity.
-
Atresia is considered, but selective survival remains unresolved.
The paper measures apoptotic follicles using TUNEL staining and reports a reduction after VB124 treatment. Thus, follicular loss is included experimentally.
Nevertheless, molecular profiling examines oocytes that survived long enough to be retrieved. It cannot distinguish changes occurring within ageing oocytes from changes in which oocytes survive follicular selection. Systemic VB124 could also improve the surrounding follicular environment, contributing to the observed fertility benefit.
For the mitochondrial citrate and acetyl-CoA mechanism, the results identify a potentially relevant upstream disturbance in mitochondrial substrate availability. They do not directly test citrate export, nuclear acetyl-CoA, histone acetylation or transcriptional elongation. The chromatin mark examined, H3K9me3, is histone methylation. Measuring these additional processes alongside metabolic flux would establish whether they contribute to the benefits attributed here primarily to restored energy metabolism.